Maybe the total balance of results is better for immunosuppressed oncologic patients.
Or maybe it is just a form of medical nationalism, given that the leader of the Remdesivir scientific team, Tomáš Cihlář, is a Czech scientist.
We had some critical patients improve and heal on remdesivir, though. I wonder how big of a role genetic diversity plays. There are many uncertain suspicions that Covid hits some people harder than others based not just on lifestyle, but things such as blood groups.
Research into that will be a good PhD material for years to come.
Or maybe it is just a form of medical nationalism, given that the leader of the Remdesivir scientific team, Tomáš Cihlář, is a Czech scientist.
We had some critical patients improve and heal on remdesivir, though. I wonder how big of a role genetic diversity plays. There are many uncertain suspicions that Covid hits some people harder than others based not just on lifestyle, but things such as blood groups.
Research into that will be a good PhD material for years to come.